Susquehanna International Group’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-12,600
| Closed | -$73.6K | – | 14076 |
|
|
2022
Q4 | $73.6K | Sell |
12,600
-17,000
| -57% | -$89.4K | ﹤0.01% | 11191 |
|
|
2022
Q3 | $198K | Sell |
29,600
-71,100
| -71% | -$431K | ﹤0.01% | 10859 |
|
|
2022
Q2 | $424K | Buy |
+100,700
| New | +$398K | ﹤0.01% | 8679 |
|
|
2022
Q1 | – | Sell |
-21,700
| Closed | -$68K | – | 14380 |
|
|
2021
Q4 | $68K | Buy |
+21,700
| New | +$72.2K | ﹤0.01% | 12400 |
|
|
2020
Q2 | – | Sell |
-50,900
| Closed | -$450K | – | 11217 |
|
|
2020
Q1 | $450K | Buy |
50,900
+37,600
| +283% | +$371K | ﹤0.01% | 7157 |
|
|
2019
Q4 | $123K | Buy |
+13,300
| New | +$94.2K | ﹤0.01% | 9046 |
|
|
2019
Q3 | – | Sell |
-21,500
| Closed | -$258K | – | 11045 |
|
|
2019
Q2 | $258K | Sell |
21,500
-5,300
| -20% | -$57K | ﹤0.01% | 8617 |
|
|
2019
Q1 | $323K | Buy |
+26,800
| New | +$395K | ﹤0.01% | 7087 |
|
|
2018
Q4 | – | Sell |
-22,100
| Closed | -$328K | – | 10267 |
|
|
2018
Q3 | $328K | Buy |
22,100
+3,300
| +18% | +$51.9K | ﹤0.01% | 7314 |
|
|
2018
Q2 | $316K | Sell |
18,800
-33,600
| -64% | -$653K | ﹤0.01% | 7738 |
|
|
2018
Q1 | $1.2M | Buy |
52,400
+43,700
| +502% | +$972K | ﹤0.01% | 4874 |
|
|
2017
Q4 | $225K | Sell |
8,700
-22,600
| -72% | -$455K | ﹤0.01% | 8066 |
|
|
2017
Q3 | $462K | Sell |
31,300
-1,400
| -4% | -$20.3K | ﹤0.01% | 6655 |
|
|
2017
Q2 | $456K | Sell |
32,700
-100
| -0.3% | -$1.47K | ﹤0.01% | 6824 |
|
|
2017
Q1 | $560K | Buy |
32,800
+22,800
| +228% | +$273K | ﹤0.01% | 6283 |
|
|
2016
Q4 | $103K | Sell |
10,000
-5,800
| -37% | -$53K | ﹤0.01% | 9072 |
|
|
2016
Q3 | $160K | Buy |
+15,800
| New | +$173K | ﹤0.01% | 7741 |
|
|
2015
Q4 | – | Sell |
-23,800
| Closed | -$447K | – | 10144 |
|
|
2015
Q3 | $447K | Buy |
23,800
+13,600
| +133% | +$231K | ﹤0.01% | 7332 |
|
|
2015
Q2 | $152K | Buy |
+10,200
| New | +$155K | ﹤0.01% | 9484 |
|
Susquehanna International Group's CNCE Position: Q1 2023 in Review
Susquehanna International Group sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2023, closing a stake of 240,190 shares — an estimated $1.4M sold.
Susquehanna International Group first reported a position in CNCE in Q2 2014 and held it in 17 quarters. The position peaked at $1.4M in Q4 2022. 0 funds tracked by Wall St. Rank hold CNCE as of Q1 2023.
- Susquehanna International Group reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Susquehanna International Group sold 240,190 Concert Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.4M.
- Susquehanna International Group first reported a position in Concert Pharmaceuticals, Inc. in Q2 2014 and held it in 17 quarters.
- Susquehanna International Group's Concert Pharmaceuticals, Inc. position peaked at $1.4M in Q4 2022.
- 0 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2023.
Based on Susquehanna International Group's 13F filing for Q1 2023, filed 16 May 2023.